This prospective study involving clinical observation with laboratory and ultrasound support was carried out at a private clinic, Dabgari Gardens Peshawar. To assess the effect of Aspirins 75 mg a day in the prevention of IUGR and pre-clampsia, for one year from January 2001 to December, 2001. One hundred and thirty patients with previous history of IRGR and IUD were given 75 mg Aspirin from from 14th to 34th week of pregnancy and were followed throughout pregnancy to see the effects of Aspirin on the fetal growth and maternal hypertension. The incidence of the patient regarding anti hypertension therapy was also noted and the neonatal outcome was recorded. The side effect of the Aspirin on the mother and the newborn was also checked. All the patients had twice monthly antenatal checkup. At each visit fundal height, weight gain, blood pressure estimation was done and recorded in patients` notes. Fetal growth was assessed by serial ultrasounds. Biochemical estimation with blood urea nirtrogen, uric acid and S.creatinine was also done early in pregnancy, at 28 weeks and at 36 weeks. 27 % of the patients required antihypertensive therapy. While 23 % of the babies showed intra uterine fetal growth retardation. Incidence of I.U.D.was 2.6 %. Caesarian section rate was 19%. We conclude that more trials are needed to establish the role of low does aspirin in the prevention of pregnancy induced hypertension and IUGR in properly selected cases.